Global diversity and antimicrobial resistance of typhoid fever pathogens: Insights from a meta-analysis of 13,000 Salmonella Typhi genomes Megan E Carey, Zoe A Dyson, Danielle J Ingle, Buddha Basnyat, Abhilasha Karkey etc. Stephen Baker, Kathryn E Holt; Global Typhoid Genomics Consortium Group Authorship Elife September 12, 2023 DOI: 10.7554/eLife.85867
Diagnostics for Typhoid Fever – Current Perspectives and Future Outlooks for Product Development and Access Jyotshna Sapkota, Tamalee Roberts, Buddha Basnyat, Stephen Baker, Lee M Hampton, Sabine Dittrich Open Forum Infect Dis June 2, 2023 DOI: 10.1093/ofid/ofad120
Validation of the Nelwan Score as a screening tool for the diagnosis of typhoid fever in adults in Indonesia Erni Juwita Nelwan, Luh Putu Listya Paramita, Robert Sinto, Decy Subekti, Fransiscus Nikodemus Hosea, Pringgodigdo Nugroho, Herdiman T Pohan PLoS One May 12, 2023 DOI: 10.1371/journal.pone.0256508
Public engagement during a typhoid conjugate vaccine trial in Lalitpur, Nepal- experience, challenges and lessons learnt Ashata Dahal, Mila Shakya, Dikshya Pant, Anup Adhikari, Rachel Colin-Jones, Katherine Theiss-Nyland, Andrew J Pollard, Buddha Basnyat, Shrijana Shrestha Hum Vaccin Immunother November 30, 2022 DOI: 10.1080/21645515.2022.2043104
Treatment of enteric fever (typhoid and paratyphoid fever) with cephalosporins Rebecca Kuehn, Nicole Stoesser, David Eyre, Thomas C Darton, Buddha Basnyat, Christopher Martin Parry Cochrane Database Syst Rev November 24, 2022 DOI: 10.1002/14651858.CD010452.pub2
Assessing The Impact Of A Vi-Polysaccharide Conjugate Vaccine In Preventing Typhoid Infections Among Nepalese Children – A Phase III Trial (TyVAC) TyVAC-Nepal is a participant- and observer-blind, 1:1 individually randomised trial of the typhoid conjugate vaccine (Vi-TCV) that aims to study the impact of Vi-TCC in an endemic setting. March 24, 2023
Assessing The Medium Term Impact Of A Vi-Polysaccharide Conjugate Vaccine In Preventing Typhoid Infections Among Nepali Children (TyVOID) This study is a continuation of the typhoid vaccine study (TyVAC Nepal), which aims to assess the medium-term efficacy of the Typhoid Conjugate Vaccine (TCV) in children by comparing the relative risk of typhoid fever in a TCV cohort initially vaccinated in 2017/2018 with TCV cohorts vaccinated in 2020 and 2021. March 24, 2023
Cefixime & Azithromycin Vs Azithromycin Alone For The Out-Patient Treatment Of Typhoid Fever In South Asia – A Randomised Comparative Controlled Trial (ACT Asia) The primary objective of the ACT-South Asia is to determine if the combination of azithromycin and cefixime for seven days results in significantly fewer treatment failures when compared with the current standard regimen of azithromycin alone for seven days in the out-patient treatment of children and adults with uncomplicated typhoid fever (infection due to Salmonella Typhi and Salmonella Paratyphi A) in South Asia. March 24, 2023
Seed Awards Tales of typhoid An animated video to explain typhoid in a culturally appropriate setting. The video has gotten positive feedback from the viewers including students, teachers, and others. June 8, 2023
The Emergence And Impact Of Azithromycin-Resistant Salmonella Enterica Serovar Typhimurium This study will decode the genetics of S. Typhi samples from South Asia obtained from the ACT-South Asia trial to investigate the epidemiological and evolutionary pathways of azithromycin-resistant S. Typhi. May 24, 2023
